167.23  -0.04 (-0.02%)		04-24 14:19
Open: 168.18 High: 169.34 Volume: 308,652		Pre. Close: 167.27 Low: 165.85 Market Cap: 11,710(M)

Short term
Mid term
Targets	6-month :	202.07	1-year :	210.25
Resists	First :	173	Second :	180
Pivot price	170.07
Supports	First :	161.67	Second :	134.51
MAs	MA(5) :	165.93	MA(20) :	169.43
	MA(100) :	187.25	MA(250) :	210.99
MACD	MACD :	-1.7	Signal :	-1.5
%K %D	K(14,3) :	24.8	D(3) :	22.3
RSI	RSI(14): 45.2
52-week	High :	335.91	Low :	125.81

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PODD ] has closed above bottom band by 35.8%. Bollinger Bands are 17.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	168.97 - 170.16	170.16 - 171.08
Low:	162.39 - 163.65	163.65 - 164.63
Close:	165.63 - 167.57	167.57 - 169.09

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Wed, 24 Apr 2024
Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect - Zacks Investment Research

Tue, 23 Apr 2024
(PODD) Trading Advice - Stock Traders Daily

Sun, 14 Apr 2024
Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors - Simply Wall St

Sun, 31 Mar 2024
Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD) - Simply Wall St

Tue, 19 Mar 2024
Here's Why Insulet (PODD) Detracted in Q4 - Yahoo Finance

Wed, 28 Feb 2024
Insulet (PODD) Q4 Earnings, Revenues Top Mark, Margins Expand - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	70 (M)
Shares Float	70 (M)
Held by Insiders	0.3 (%)
Held by Institutions	103.5 (%)
Shares Short	3,120 (K)
Shares Short P.Month	2,680 (K)

EPS	2.94
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	10.47
Profit Margin	12.1 %
Operating Margin	26 %
Return on Assets (ttm)	6 %
Return on Equity (ttm)	34.1 %
Qtrly Rev. Growth	37.9 %
Gross Profit (p.s.)	0
Sales Per Share	24.27
EBITDA (p.s.)	4.4
Qtrly Earnings Growth	504.2 %
Operating Cash Flow	146 (M)
Levered Free Cash Flow	-38 (M)

PE Ratio	56.8
PEG Ratio	3
Price to Book value	15.93
Price to Sales	6.87
Price to Cash Flow	80.26

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.